Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- RAD +11.6% (also announces terms for pharmaceutical distribution with McKesson), MLHR +6.1%, BB +5.4%, RCII+4.3%
M&A news:
- MO +0.2% (invests $12.8B in Juul)
Select cannabis stocks trading higher:
- TLRY +12.3% (Ambev's Labatt Brewing partners with Tilray on research for non-alcoholic beverages containing cannabis extracts), APHA +3.7%, NBEV +1.8% (TLRY / ABEV news; Highpark's Marley Brands is partners with NBEV), ACB +1.7%, CGC +1.4%, CRON +1.2%
Other news:
- AGEN +57.2% (I/O partnership with Gilead, buying 11M shares at $2.70)
- AIMT +12.4% (higher following DBVT news on peanut drug trial update)
- SB +8.9% (authorizes common stock repurchase program of up to 3.0 mln shares)
- XON +8.4% (deal with Merck KGaA for CAR-T)
- BILI +6.7% (Alibaba partnership)
- NWL +5.4% (Carl Icahn increases active stake), CE +4.8% (to join S&P 500)
- ABEV +3.3% (Ambev's Labatt Brewing partners with Tilray on research for non-alcoholic beverages containing cannabis extracts)
- CNDT +3.1% (Darwin Deason discloses 5.8% stake)
Analyst comments:
- ZUO +4% (upgraded to Strong Buy at Needham)
- PSX +0.8% (upgraded to Buy at Jefferies)
- SNV +0.6% (upgraded to Outperform from Neutral at Robert W. Baird)